173 related articles for article (PubMed ID: 2549584)
21. Expression of the activation antigen, 4F2, by non-Hodgkin's lymphomas of B-cell phenotype.
Lewandrowski KB; Medeiros LJ; Harris NL
Cancer; 1990 Sep; 66(6):1158-64. PubMed ID: 1698116
[TBL] [Abstract][Full Text] [Related]
22. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma.
Le Beau MM; Bitter MA; Larson RA; Doane LA; Ellis ED; Franklin WA; Rubin CM; Kadin ME; Vardiman JW
Leukemia; 1989 Dec; 3(12):866-70. PubMed ID: 2555633
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow transplantation for childhood Ki-1 lymphoma.
Chakravarti V; Kamani NR; Bayever E; Lange B; Herzog P; Sanders JE; August CS
J Clin Oncol; 1990 Apr; 8(4):657-60. PubMed ID: 2156024
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical evidence of abnormal expression of the antioncogene-encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas.
Doglioni C; Pelosio P; Mombello A; Scarpa A; Chilosi M
Hematol Pathol; 1991; 5(2):67-73. PubMed ID: 1680118
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.
Armitage JO; Vose JM; Linder J; Weisenburger D; Harrington D; Casey J; Bierman P; Sorensen S; Hutchins M; Moravec DF
J Clin Oncol; 1989 Dec; 7(12):1783-90. PubMed ID: 2585020
[TBL] [Abstract][Full Text] [Related]
26. Detection of Epstein-Barr virus genome in Ki-1 (CD30)-positive, large-cell anaplastic lymphomas using the polymerase chain reaction.
Ross CW; Schlegelmilch JA; Grogan TM; Weiss LM; Schnitzer B; Hanson CA
Am J Pathol; 1992 Aug; 141(2):457-65. PubMed ID: 1323222
[TBL] [Abstract][Full Text] [Related]
27. The development of a Ki-1-positive large cell non-Hodgkin's lymphoma in pagetoid reticulosis.
Ralfkiaer E; Thomsen K; Agdal N; Hou-Jensen K; Wantzin GL
Acta Derm Venereol; 1989; 69(3):206-11. PubMed ID: 2566223
[TBL] [Abstract][Full Text] [Related]
28. Anaplastic large-cell Ki-1 malignant lymphomas. Recognition, biological and clinical implications.
Kinney MC; Greer JP; Glick AD; Salhany KE; Collins RD
Pathol Annu; 1991; 26 Pt 1():1-24. PubMed ID: 1849627
[TBL] [Abstract][Full Text] [Related]
29. A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.
Schnell R; Staak O; Borchmann P; Schwartz C; Matthey B; Hansen H; Schindler J; Ghetie V; Vitetta ES; Diehl V; Engert A
Clin Cancer Res; 2002 Jun; 8(6):1779-86. PubMed ID: 12060617
[TBL] [Abstract][Full Text] [Related]
30. Ki-1 lymphoma and Hodgkin's disease.
Pileri S; Mazza P; Zinzani PL; Poggi S; Poletti G; Falini B; Tura S
Haematologica; 1989; 74(3):333-4. PubMed ID: 2555287
[No Abstract] [Full Text] [Related]
31. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity.
Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F
Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573
[TBL] [Abstract][Full Text] [Related]
32. [KI-1-positive, anaplastic, large-cell lymphoma related to Hodgkin's disease].
Veiga M; Fresno MF; Pérez del Río MJ; García I; Madrigal B; Herrero A
Sangre (Barc); 1997 Feb; 42(1):81-4. PubMed ID: 9229809
[TBL] [Abstract][Full Text] [Related]
33. Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkin's disease.
Rosso R; Paulli M; Magrini U; Kindl S; Boveri E; Volpato G; Poggi S; Baglioni P; Pileri S
Virchows Arch A Pathol Anat Histopathol; 1990; 416(3):229-35. PubMed ID: 1967860
[TBL] [Abstract][Full Text] [Related]
34. [In vivo imaging of Hodgkin's lymphomas using monoclonal antibodies].
Pfreundschuh M; Carde P; Da Costa L; Manil L; Lumbroso JD; Caillou B; Boudet F; Ricard M; Hayat M; Diehl V
Onkologie; 1989 Aug; 12 Suppl 1():30-3. PubMed ID: 2555758
[TBL] [Abstract][Full Text] [Related]
35. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
[TBL] [Abstract][Full Text] [Related]
36. Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases.
Chott A; Kaserer K; Augustin I; Vesely M; Heinz R; Oehlinger W; Hanak H; Radaszkiewicz T
Am J Surg Pathol; 1990 May; 14(5):439-48. PubMed ID: 2158242
[TBL] [Abstract][Full Text] [Related]
37. [Primary cutaneous Ki-1-lymphoma].
Berger H; Bergholz M; Heil M
Z Hautkr; 1990 Mar; 65(3):277-81. PubMed ID: 2160150
[TBL] [Abstract][Full Text] [Related]
38. Correlation of Ki 67 proliferative index with clinical and pathological features on tissue sections of non Hodgkins lymphoma by immunostaining.
Naz E; Mirza T; Aziz S; Ali A; Danish F
J Pak Med Assoc; 2011 Aug; 61(8):748-52. PubMed ID: 22355994
[TBL] [Abstract][Full Text] [Related]
39. CD30 expression in follicular lymphoma.
Piris M; Gatter KC; Mason DY
Histopathology; 1991 Jan; 18(1):25-9. PubMed ID: 1849500
[TBL] [Abstract][Full Text] [Related]
40. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
